HaploX Stock

haplox.cnHealthcareFounded: 2014Funding to Date: $42.87MM

HaploX aims to integrate liquid biopsy technology, gene sequencing, artificial intelligence, big data, and other technologies to improve the management of cancer patients.

Register for Details

For more details on financing and valuation for HaploX, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for HaploX.

Register Today

Team

Management Team

Wen Yuan
Chief Financial Officer & Co-Founder
Fang Wen
Chief Operating Officer & Co-Founder
Chen Shifu Ph.D
Chief Technology Officer & Co-Founder
Yan Ming Xu Ph.D
Co-Founder, Chief Executive Officer & Chairman

Board Members

Yan Ming Xu Ph.D

Other companies like HaploX in the Healthcare sector

Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$4.8B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM

News

A group of investors including SBCVC and Kexin Capital have backed a $32 million funding round for China’s HaploX Biotechnology. ,Greater China,Healthcare,Technology,Early-stage ,China,Softbank China Venture Capital,Venture